<DOC>
	<DOCNO>NCT02070302</DOCNO>
	<brief_summary>This study prospective double blind control randomized trial ten patient diagnose Carpal Tunnel Syndrome ( CTS ) . The study complete office medical practice Arizona . Patients meet inclusion criterion randomly distribute two group : BOTOX® ( onabotulinumtoxin A ) injection group Normal Saline Injection ( NS ) ( Placebo group ) . Each group consist five randomly assign individual .</brief_summary>
	<brief_title>BOTOX® ( Onabotulinumtoxin A ) Injection ( ) Treatment Carpal Tunnel Syndrome</brief_title>
	<detailed_description>This pilot study , assist determine appropriate BOTOX® ( onabotulinumtoxin A ) dose injection location patient suffer CTS . Outcome measure obtain follow-up 6 , 12 , 18 week post BOTOX® ( onabotulinumtoxin A ) injection post saline injection use scale instrument baseline , namely Levine scale , JAMAR pinch dynamometer , EDX/NCS NMUS . These measurement use identify effectiveness BOTOX® ( onabotulinumtoxin A ) decrease thenar muscle strength , appropriate BOTOX® ( onabotulinumtoxin A ) injection dosing , ability decrease inflammation , median nerve dysfunction , edema , symptom pain , numbness , tingle often associate CTS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Carpal Tunnel Syndrome</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Patient history : evaluate use Levine Scale CTS , selfadministered questionnaire ass function severity CTS . Physical Exam : include use JAMAR pinch dynamometer quantify initial baseline strength confirm decrease pinch strength post injection verify effective BOTOX® ( onabotulinumtoxin A ) injection . Electrodiagnostics ( EDX ) : The following criterion would establish CTS EDX namely baseline electromyogram ( EMG ) nerve conduction study ( NCS ) : ) median nerve distal motor latency ( DML ) &gt; 4.3ms &gt; 0.9ms ulnar nerve DML b ) median distal sensory latency ( DSL ) D1 &gt; 2.9ms &gt; 0.4ms radial nerve D1 DSL . c ) median D2 DSL &gt; 3.7ms &gt; 0.4ms ulnar nerve D5 DSL ( 5 ) . ) median mixed nerve palmtowrist latency ( 8cm ) &gt; 2.2ms &gt; .3ms ulnar mixed nerve palmtowrist latency ( 8cm ) . Imaging &amp; Measurements ( NMUS ) : Carpal tunnel image obtain transverse plane neutral relaxed position level pisiform longitudinally neutral Dynamic Stress Testing ( DST ) ( 5 , 27 ) A Sonosite MTurbo 613 MHz ultrasound system another similar system ( + 2 % accuracy ) . Measurements : Transverse image CT measure median nerve cross sectional area ( CSA ) level pisiform bone . CSA measurement great 11 mm2 ( 5 , 27 ) indicative CTS . Borderline CSA measurement would require wrist forearm ratio ( WFR ) measurement WFR &gt; 1.5 ( 5 , 36 ) . Patients need CSA &gt; 11mm2 , ( WFR &gt; 1.5 ) show median nerve compression DST least 30 % include . Patients prior carpal tunnel surgery , prior history BOTOX® ( onabotulinumtoxin A ) injection Steroid injection two month prior three month BOTOX® ( onabotulinumtoxin A ) CTS injection , median nerve denervation needle EMG Major limb trauma surgery , dysphagia Neuromuscular junction disorder ( ie : Myasthenia gravis LambertEaton syndrome ) Currently pregnant breast feeding Patients severe CTS identify Levine scale &gt; 4 , electrodiagnostics , and/or unable meet inclusion criterion identify would exclude participant study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>